Area of research
Immunology · Oncology
Research interest
Research interests include Immune cells in cancer, Melanoma and MAPK Pathways, Nanoplatforms for cancer theranostics, and Chemokine receptors and signaling.
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma
Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
BRAF inhibitors in cancer therapy